Kyle Huh

Associate
Full contact info

Experience

Neumora Therapeutics – $250.1 Million IPO

September 15, 2023

Cooley advised the underwriters on the $250.1 million initial public offering of Neumora Therapeutics, a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Grady Chang
Associate, Los Angeles Santa Monica
Madison (JJ) Meng
Associate, San Francisco
Kyle Huh
Associate, Palo Alto
Peter A. Haddad
Associate, San Diego
Heidi Ausman
Senior Paralegal, San Diego
Lila Hope
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Mika Reiner Mayer
Partner, Palo Alto
Barbara Mirza
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Jennifer Raab
Partner, Palo Alto
Madhuri Roy
Partner, Palo Alto
Erica Russell
Associate, San Francisco
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Karen Tsai
Special Counsel, Washington, DC
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto

Related Practices & Industries

Super Group Completes Warrant Exchange Offer and Consent Solicitation

January 10, 2023

Cooley advised Super Group, the holding company for top global online sports betting and gaming businesses Betway and Spin, on the completion of its public warrant exchange offer and warrant consent solicitation, as well as its related earnout shares waiver. Jointly, the measures removed the potential issuance of approximately 78.8 million of Super Group’s ordinary shares, lowering Super Group’s potential fully diluted share count by 13.6%. The exchange offer and consent solicitation simplified Super Group’s capital structure, increased its public float and reduced the potentially dilutive impact of the warrants.

Related contacts

Justin Stock
Managing Partner – London, London
Brian Leaf
Partner, Reston
Rita Sobral
Associate, London
Kyle Huh
Associate, Palo Alto
Harry Calkin
Associate, London
Aaron Pomeroy
Partner, Colorado
Xander Lee
Partner, Los Angeles Santa Monica
Rick Jantz
Associate, Los Angeles Santa Monica

Related Practices & Industries

Grindr Agrees to Merge With SPAC Tiga Acquisition Corp.

May 11, 2022

Cooley is advising Grindr, the #1 social network for the LGBTQ+ community, on its definitive agreement to merge with special purpose acquisition company (SPAC) Tiga Acquisition Corp. – a combination that will result in Grindr becoming a publicly listed company. Partners Dave Peinsipp, Jamie Leigh, Kristin VanderPas, Garth Osterman, Will Cai, Jeffrey Tolin and Aaron Pomeroy, as well as associates Sangitha Palaniappa, Kyle Huh, JJ Meng, Dannielle Antone, Mike Lam and Meera Patel, led the Cooley team advising Grindr.

Read more

Related contacts

David Peinsipp
Partner, San Francisco
Jamie Leigh
Partner, San Francisco
Garth Angelo Osterman
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Will Cai
Partner, Hong Kong
Jeffrey J. Tolin
Partner, New York
Aaron Pomeroy
Partner, Colorado
Travis LeBlanc
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Lei Shen
Partner, Chicago
Howard Morse
Partner, Washington, DC
Charles Haley
Partner, Palo Alto
Patrick Van Eecke
Partner, Brussels
Len Jacoby
Partner, New York
Guadalupe Sampedro
Partner, London
Christopher Kimball
Partner, Washington, DC
John Clark
Partner, London
Patrick Flanagan
Partner, New York
Michael Tollini
Partner, Washington, DC
Stella Sarma
Special Counsel, Brussels
Bridget R. Reineking
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Miriam Petrillo
Partner, Chicago
Karen Tsai
Special Counsel, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
J.G. Harrington
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Annie Froehlich
Partner, Washington, DC
Sangitha Palaniappa
Associate, Palo Alto
Kyle Huh
Associate, Palo Alto
Madison (JJ) Meng
Associate, San Francisco
Dannielle Antone
Associate, San Francisco
Mike Lam
Associate, Los Angeles Santa Monica
Meera Patel
Associate, San Francisco
Enrique Gallego Capdevila
Special Counsel, Brussels
Patrick Sharma
Associate, Los Angeles Santa Monica
Anisha Mohin
Associate, New York
Eileen Leman
Associate, Los Angeles Downtown
Ajay Athavale
Associate, San Francisco
Alexandra Leavy
Associate, New York
Sarah Oliai
Associate, Washington, DC
Kristopher Kleiner
Special Counsel, Colorado
Grady Chang
Associate, Los Angeles Santa Monica
Sam Meiklejohn
Associate, London
Bartholomäus Regenhardt
Associate, Brussels
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Global Blood Therapeutics – $345 Million Convertible Senior Notes Offering

January 4, 2022

Cooley advised the initial purchasers on Global Blood Therapeutics’ Rule 144A offering of $345 million aggregate principal amount of 1.875% Convertible Senior Notes due 2028.  In connection with the offering, GBT entered into capped call transactions. Goldman Sachs & Co. and Jefferies acted as joint book-running managers for the offering. Global Blood Therapeutics is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Partners Kristin VanderPas, Charlie Kim, Dave Peinsipp, Mischi a Marca and Jason Savich led the Cooley team.

Related contacts

Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
David Peinsipp
Partner, San Francisco
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Denny Won
Partner, San Francisco
Kyle Huh
Associate, Palo Alto
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Mike Lam
Associate, Los Angeles Santa Monica
Jessica Wade
Paralegal Specialist, San Diego
Timothy Nguyen
Special Counsel, San Francisco
Ellie Guadiana
Partner, Los Angeles Santa Monica

Related Practices & Industries

PROCEPT BioRobotics – $188.5 Million IPO

September 15, 2021

Cooley advised the underwriters on PROCEPT BioRobotics’ $188.5 million initial public offering of 7,539,400 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. BofA Securities, Inc. and Goldman Sachs & Co. LLC acted as joint lead book-running managers for the offering. PROCEPT BioRobotics, whose securities now trade on the Nasdaq Global Market under the symbol “PRCT,” is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. Partners Charlie Kim, Kristin VanderPas and Dave Peinsipp led the Cooley team.

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
David D. Kim
Associate, San Francisco
Kyle Huh
Associate, Palo Alto
Marjorie Roesser
Associate, San Francisco

Related Practices & Industries

View more

Admissions & credentials

California

Illinois

New York

Memberships & affiliations

Chartered Financial Analyst, CFA Institute (expired June 2020)

Financial Risk Manager, Global Association of Risk Professionals